Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Annovis Bio Inc (NY: ANVS )

6.800 +0.010 (+0.15%)
Streaming Delayed Price Updated: 9:55 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Annovis Bio Inc

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
3 Growth Stocks to Sell in February Before They Bottom
Discover why these growth stocks to sell are facing adversities in automotive retail, aerospace, defense and biotechnology. 
Via InvestorPlace
Dow Edges Lower; US Composite PMI Rises In January
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... 
Via Benzinga
Recap: Annovis Bio Q1 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Rises Over 1%; DuPont Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Annovis Bio (ANVS) Stock Is Getting Hammered
Annovis Bio shares are trading lower by 20.6% to $9.24 during Wednesday's session. The company announced a delay in the release of Phase III study data for buntanetap in Parkinson's Disease. 
Via Benzinga
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.29% to 38,013.76 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet. 
Via MarketBeat
Topics Bonds
Exposures Debt Markets
Annovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s Patients
From Annovis Bio
Via Business Wire
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Annovis Bio (ANVS) Stock Hit A New 52-Week Low Today
Annovis Bio Inc (NYSE: ANVS) shares are trading lower by 17.9% to $6.69 Tuesday morning after the company announced a public offering of 1.25 million units, each consisting of one common stock share... 
Via Benzinga
Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 38.8% to $0.1250 in pre-market trading. LumiraDX shares fell 25% on Monday after the company announced the receipt of the Nasdaq delisting... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Annovis Bio Announces Pricing of $7.5 Million Public Offering
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Announces Launch of Proposed Public Offering
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Showcases Promising Progress in Novel Drug Development at the 2023 Clinical Trials on Alzheimer's Disease Conference
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Announces Second Quarter 2023 Financial Results and Provides Corporate Update
From Annovis Bio, Inc.
Via Business Wire
3 Biotech Stocks to Buy Before Drug Trials End
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains. 
Via InvestorPlace
Continued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International Conference
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Announces the Filing of a Groundbreaking Patent
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Continue Phase III Trial of Buntanetap for Parkinson’s Disease Patients from the Independent Data and Safety Monitoring Board (DSMB)
From Annovis Bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Tesla, NIO And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Quarterly Gain Still Eludes Dow Despite Triple-Digit Lead
The Dow Jones Industrial Average is boasting a triple-digit lead this afternoon, as investors unpack this morning's flood of inflation data. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS